Hernia News and Research

RSS

A hernia is protrusion of an organ or the muscular wall of an organ through the cavity that normally contains it. A hiatal hernia occurs when the stomach protrudes upwards into the mediastinum through the esophageal opening in the diaphragm.

joimax moves into larger premises in Germany, US

The medical devices company joimax(R) GmbH is moving into new premises both in Germany and the US. "Growth requires space" had already been the motto of the last company move back in 2005.

16 Jun 2010

HyperBranch Medical Technology granted CE Mark for Adherus Spinal Sealant

HyperBranch Medical Technology, Inc. announced today that it has received a CE Mark for Adherus Spinal Sealant. Adherus Spinal Sealant is used in spinal surgeries where a water tight seal is required to prevent cerebrospinal fluid leakage from the dural repair. Prevention of cerebrospinal fluid leaks should benefit the patient in shorter hospital stays and fewer post-surgical complications such as reduced pain and fewer infections.

15 Jun 2010

First hospital in Mexico to use GORE HELEX Septal Occluder for transcatheter closure of ASD

W. L. Gore & Associates (Gore) today announced that Instituto Nacional De Cardiologia in Mexico City, Mexico, is the first hospital in the country to use the GORE® HELEX Septal Occluder for the transcatheter closure of an atrial septal defect (ASD). Department Chief, Dr. Carlos Zabal and Dr. Jose Garcia Montes of the Instituto Nacional de Cardiologia, in Mexico City, achieved the milestone procedure in March, 2010.

14 Jun 2010

Gore introduces new internet cloud-based 3-D modeling system and case planning aid

W. L. Gore & Associates (Gore) today announced the launch of a new internet cloud-based 3-D advanced visualization and decision support system to aid physicians in case planning at the Society for Vascular Surgery's 2010 Vascular Annual Meeting being held in Boston, Massachusetts.

11 Jun 2010

Atrium Medical wins Supplier Performance Award

Atrium Medical Corporation today announced that it is a winner of the Supplier Performance Award, presented by the Premier healthcare alliance. Premier contracts with more than 800 suppliers and Atrium is one of 65 contracted suppliers to receive the Performance Award. Winners are recognized for their outstanding management of Premier agreements and drive toward the mutual goal of providing clinical and financial value to the not-for-profit hospital members of the Premier alliance.

10 Jun 2010

FDA approves 45mm GORE TAG Thoracic Endoprosthesis device

W. L. Gore & Associates (Gore) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market a 45 mm diameter version of the GORE® TAG® Thoracic Endoprosthesis for treatment of aneurysms of the descending thoracic aorta. The larger diameter device allows treatment of TAAs with proximal and distal neck diameters ranging from 37 - 42 mm and is now available for commercial use in the U.S.

7 Jun 2010

Kensey Nash granted FDA 510(k) clearance for Meso BioMatrix ECM product

Kensey Nash Corporation, a leading medical technology company that provides innovative resorbable biomaterial technology for a wide range of medical procedures, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its second extracellular matrix (ECM) product, the Meso BioMatrix™ product.

27 May 2010

Synovis Life Technologies' second-quarter 2010 net revenue up 19%

Synovis Life Technologies, Inc., today reported record revenue for the second quarter ended April 30, 2010.

26 May 2010

New laparoscopic procedure for hernias

Christopher Haarstad, 36, was surprised at how well he felt a couple of hours after having laparoscopic surgery for a hernia in March.

14 May 2010

FDA approves Abbott's CREON sNDA including dosing guidance for treating EPI due to CP, pancreatectomy

Abbott announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for CREON® (pancrelipase) Delayed-Release Capsules that now includes dosing guidance in the prescribing information specific to patients with limited production of enzymes in the pancreas (exocrine pancreatic insufficiency) due to chronic pancreatitis (CP) or removal of the pancreas (pancreatectomy). Prior to this FDA approval, dosing guidance for medications such as CREON was based on patients with cystic fibrosis.

3 May 2010

TGRD presents positive results from Phase 3 studies of azilsartan medoxomil for lowering SBP at 25th ASH

Takeda Global Research & Development Center, Inc., U.S., (TGRD U.S.) today announced results from pivotal phase 3 studies of azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB), demonstrating greater 24-hour systolic blood pressure (SBP) reduction compared to commonly prescribed ARBs olmesartan medoxomil and valsartan.

3 May 2010

SARcode presents positive results from Phase 2 study of SAR 1118 ophthalmic solution at Dry Eye Summit

SARcode Corporation, a privately-held biotechnology company focused on developing a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists, today announced results of a 230 patient Phase 2 proof-of-concept study evaluating topical SAR 1118 ophthalmic solution in the treatment of aqueous deficient dry eye (keratoconjunctivitis sicca).

3 May 2010

PolyTouch Medical files Premarket 510(k) application for PatchAssist laparoscopic mesh deployment device

PolyTouch Medical Ltd., a leading developer of laparoscopic hernia mesh placement technologies, today announced that it has filed a Premarket 510(k) Application with the US Food and Drug Administration for PatchAssist, an Innovative Laparoscopic Mesh Deployment and Placement Device that enables accurate mesh placement in laparoscopic ventral hernia repair potentially reducing procedure time by 30%-50%.

3 May 2010

Stimatix reports interim results from artificial sphincter trial for restoring bowel control in people with stoma

Stimatix GI, located in the Misgav Venture Accelerator, has reported encouraging interim results in its animal trials of the AOS-C1000 artificial sphincter, designed to provide stoma patients with a new means of bowel control.

3 May 2010

EGS announces presentation of TIF2 procedure clinical results at SAGES meeting

EndoGastric Solutions (EGS) today announced that new U.S. clinical results for their third generation Transoral Incisionless Fundoplication (TIF2) procedure were presented during the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) meeting April 14-17, in Washington, DC.

30 Apr 2010

RTI Biologics reports revenues of $37.8M for first-quarter 2010

RTI Biologics Inc., a leading processor of orthopedic and other biologic implants, reported operating results for the first quarter ending March 31, 2010

29 Apr 2010

TYRX receives FDA marketing clearance for AIGISRx ST antibacterial patch for soft tissue repair

TYRX, Inc. announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market AIGISRx® ST, its antibacterial product for the surgical repair of damaged or ruptured soft tissue.

28 Apr 2010

GORE VIABIL Biliary Endoprosthesis receives European CE Mark approval for expanded indication

W. L. Gore & Associates (Gore) today announced it has received European CE Mark approval for an expanded indication of the GORE® VIABIL® Biliary Endoprosthesis that allows removal of the device up to 12 months after implantation for the treatment of benign or malignant biliary strictures. The GORE® VIABIL® Biliary Endoprosthesis first received CE Mark approval in December 1999 and U.S. Food and Drug Administration (FDA) approval in January 2002 for the treatment of biliary strictures due to malignant neoplasms.

27 Apr 2010

Kaiser Permanente Medical Centers perform 67 outpatient surgeries as part of Free Surgery Day

In partnership with local community health care agencies, three Kaiser Permanente Southern California Medical Centers, opened their doors this morning to perform a total of 67 outpatient surgeries as part of a region-wide Free Surgery Day.

26 Apr 2010

City of Manchester, Anthem Blue Cross and Blue Shield enhance Compass SmartShopper Program

Citing strong interest and engagement from city employees as well as requests from school district members, the city of Manchester and Anthem Blue Cross and Blue Shield in New Hampshire announced today enhancements to the innovative Compass SmartShopper Program as well as the addition of Manchester school district employees to the project.

23 Apr 2010

Hernia News and Research

Further Reading

joimax moves into larger premises in Germany, US

HyperBranch Medical Technology granted CE Mark for Adherus Spinal Sealant

First hospital in Mexico to use GORE HELEX Septal Occluder for transcatheter closure of ASD

Gore introduces new internet cloud-based 3-D modeling system and case planning aid

Atrium Medical wins Supplier Performance Award

FDA approves 45mm GORE TAG Thoracic Endoprosthesis device

Kensey Nash granted FDA 510(k) clearance for Meso BioMatrix ECM product

Synovis Life Technologies' second-quarter 2010 net revenue up 19%

New laparoscopic procedure for hernias

FDA approves Abbott's CREON sNDA including dosing guidance for treating EPI due to CP, pancreatectomy

TGRD presents positive results from Phase 3 studies of azilsartan medoxomil for lowering SBP at 25th ASH

SARcode presents positive results from Phase 2 study of SAR 1118 ophthalmic solution at Dry Eye Summit

PolyTouch Medical files Premarket 510(k) application for PatchAssist laparoscopic mesh deployment device

Stimatix reports interim results from artificial sphincter trial for restoring bowel control in people with stoma

EGS announces presentation of TIF2 procedure clinical results at SAGES meeting

RTI Biologics reports revenues of $37.8M for first-quarter 2010

TYRX receives FDA marketing clearance for AIGISRx ST antibacterial patch for soft tissue repair

GORE VIABIL Biliary Endoprosthesis receives European CE Mark approval for expanded indication

Kaiser Permanente Medical Centers perform 67 outpatient surgeries as part of Free Surgery Day

City of Manchester, Anthem Blue Cross and Blue Shield enhance Compass SmartShopper Program

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News